Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

username:

paswword:

Shanghai Jinhe Bio-Technology Co.,Ltd. was renamed Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd.

Under the verification of Shanghai Administration for Industry&Commerce, we change the company's name from Shanghai Jinhe Bio-Technology Co.,Ltd. Into Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. in March, 2016. It is a significant step for us to transform into a pharmaceutical producing enterprise.

	Welcome to our company’s booth on API CHINA & INTERPHEX CHINA 2013, NO.: 3BE56
	Welcome to our company's booth on CPHI, ICSE & BioPh China 2013, NO.: W1B12
	Welcome to our company's booth on CPHI Worldwide 2013 (Frankfurt, Germany), NO.: 31E12
	Welcome to our company's booth on CPHI INDIA 2013, NO.: D16 in Hall 1
	The project of technical reform & innovation for our GMP plant ...
	The main building of our new GMP plant has been completed.
	Our company vigorously carries out the project of Shanghai...
	Our project was awarded the technological invention prize of Shanghai ...
	Our Project Docetaxel is ranked as Innovation fund for Technology Based Firms Projects.
	Jinhe, was granted as the honor of “2005-2006 year’s advanced private enterprise “
	Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park
	A new patent of Jinhe Bio-Tec called “a new method of Docetaxel synthesis” was published.